Robert Reiter
Robert Reiter
Professor, UCLA
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer
RE Reiter, Z Gu, T Watabe, G Thomas, K Szigeti, E Davis, M Wahl, ...
Proceedings of the National Academy of Sciences 95 (4), 1735-1740, 1998
Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
YE Whang, X Wu, H Suzuki, RE Reiter, C Tran, RL Vessella, JW Said, ...
Proceedings of the National Academy of Sciences 95 (9), 5246-5250, 1998
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer
Z Gu, G Thomas, J Yamashiro, IP Shintaku, F Dorey, A Raitano, ON Witte, ...
Oncogene 19 (10), 1288-1296, 2000
Genomic hallmarks and structural variation in metastatic prostate cancer
DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ...
Cell 174 (3), 758-769. e9, 2018
Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial
WP Fendler, J Calais, M Eiber, RR Flavell, A Mishoe, FY Feng, ...
JAMA oncology 5 (6), 856-863, 2019
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
KA Klein, RE Reiter, J Redula, H Moradi, XL Zhu, AR Brothman, DJ Lamb, ...
Nature medicine 3 (4), 402-408, 1997
Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology
JD Le, N Tan, E Shkolyar, DY Lu, L Kwan, LS Marks, J Huang, ...
European urology 67 (3), 569-576, 2015
Prostate cancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-ligand PET/CT
M Eiber, K Herrmann, J Calais, B Hadaschik, FL Giesel, M Hartenbach, ...
Journal of Nuclear Medicine 59 (3), 469-478, 2018
Value of targeted prostate biopsy using magnetic resonance–ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen
GA Sonn, E Chang, S Natarajan, DJ Margolis, M Macairan, P Lieu, ...
European urology 65 (4), 809-815, 2014
Prostate cancer detection with magnetic resonance‐ultrasound fusion biopsy: the role of systematic and targeted biopsies
CP Filson, S Natarajan, DJA Margolis, J Huang, P Lieu, FJ Dorey, ...
Cancer 122 (6), 884-892, 2016
Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process
N Craft, C Chhor, C Tran, A Belldegrun, J DeKernion, ON Witte, J Said, ...
Cancer research 59 (19), 5030-5036, 1999
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma
P Argani, C Rosty, RE Reiter, RE Wilentz, SR Murugesan, SD Leach, ...
Cancer research 61 (11), 4320-4324, 2001
Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer
AW Wyatt, M Annala, R Aggarwal, K Beja, F Feng, J Youngren, A Foye, ...
JNCI: Journal of the National Cancer Institute 109 (12), djx118, 2017
Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
H Tanaka, E Kono, CP Tran, H Miyazaki, J Yamashiro, T Shimomura, ...
Nature medicine 16 (12), 1414-1420, 2010
Low p27 expression predicts poor disease-free survival in patients with prostate cancer
The Journal of urology 159 (3), 941-945, 1998
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging …
J Calais, F Ceci, M Eiber, TA Hope, MS Hofman, C Rischpler, ...
The Lancet Oncology 20 (9), 1286-1294, 2019
Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019
S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ...
European urology 77 (4), 508-547, 2020
NCCN guidelines insights: Prostate cancer, version 1.2021: Featured updates to the NCCN guidelines
E Schaeffer, S Srinivas, ES Antonarakis, AJ Armstrong, JE Bekelman, ...
Journal of the National Comprehensive Cancer Network 19 (2), 134-143, 2021
Quality of life after surgery, external beam irradiation, or brachytherapy for early‐stage prostate cancer
MS Litwin, JL Gore, L Kwan, JM Brandeis, SP Lee, HR Withers, RE Reiter
Cancer 109 (11), 2239-2247, 2007
Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with Gleason score 9 …
AU Kishan, RR Cook, JP Ciezki, AE Ross, MM Pomerantz, PL Nguyen, ...
Jama 319 (9), 896-905, 2018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20